Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
Arsenic trioxide and all-trans retinoic acid combination safely cures human acute promyelocytic leukemia. Here, the authors show that this combination has potent anticancer activity in triple negative breast cancer by cooperatively targeting Pin1, a master regulator of oncogenic signaling networks,...
Main Authors: | Shingo Kozono, Yu-Min Lin, Hyuk-Soo Seo, Benika Pinch, Xiaolan Lian, Chenxi Qiu, Megan K. Herbert, Chun-Hau Chen, Li Tan, Ziang Jeff Gao, Walter Massefski, Zainab M. Doctor, Brian P. Jackson, Yuanzhong Chen, Sirano Dhe-Paganon, Kun Ping Lu, Xiao Zhen Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-05402-2 |
Similar Items
-
Oligomeric structure of the MALT1 tandem Ig-like domains.
by: Liyan Qiu, et al.
Published: (2011-01-01) -
Retinoic acid and arsenic for treating acute promyelocytic leukemia.
by: Guang-Biao Zhou, et al.
Published: (2005-01-01) -
UHRF1 Links the Histone Code and DNA Methylation to Ensure Faithful Epigenetic Memory Inheritance
by: Christian Bronner, et al.
Published: (2010-01-01) -
UHRF1 Links the Histone Code and DNA Methylation to Ensure Faithful Epigenetic Memory Inheritance
by: Christian Bronner, et al.
Published: (2009-01-01) -
Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
by: Xiaolan Lian, et al.
Published: (2018-05-01)